CLINICAL TRIALS PROFILE FOR WELCHOL
✉ Email this page to a colleague
All Clinical Trials for WELCHOL
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00147719 ↗ | WelChol® With Metformin in Treating Patients With Type 2 Diabetes | Completed | Daiichi Sankyo Inc. | Phase 3 | 2004-06-01 | The purpose of the study is to see how safe and effective and tolerable the use of colesevelam hydrochloride is for type 2 diabetes when added to metformin alone or in combination with other anti-diabetic drugs. |
NCT00147719 ↗ | WelChol® With Metformin in Treating Patients With Type 2 Diabetes | Completed | Daiichi Sankyo, Inc. | Phase 3 | 2004-06-01 | The purpose of the study is to see how safe and effective and tolerable the use of colesevelam hydrochloride is for type 2 diabetes when added to metformin alone or in combination with other anti-diabetic drugs. |
NCT00147745 ↗ | Effects of Colesevelam on How the Body Responds to Insulin in Patients With Type 2 Diabetes | Completed | Daiichi Sankyo Inc. | Phase 2 | 2005-06-01 | This study is designed to assess the potential mechanism of action by which WelChol® (colesevelam) may improve blood glucose control in patients with type 2 diabetes |
NCT00147745 ↗ | Effects of Colesevelam on How the Body Responds to Insulin in Patients With Type 2 Diabetes | Completed | Daiichi Sankyo, Inc. | Phase 2 | 2005-06-01 | This study is designed to assess the potential mechanism of action by which WelChol® (colesevelam) may improve blood glucose control in patients with type 2 diabetes |
NCT00147758 ↗ | WelChol® and Sulfonylurea in Treating Patients With Type 2 Diabetes | Completed | Daiichi Sankyo Inc. | Phase 3 | 2004-06-01 | The purpose of the study is to see how safe and effective and tolerable the use of colesevelam hydrochloride is for type 2 diabetes when added to sulfonylurea alone or in combination with other anti-diabetic drugs. |
NCT00147758 ↗ | WelChol® and Sulfonylurea in Treating Patients With Type 2 Diabetes | Completed | Daiichi Sankyo, Inc. | Phase 3 | 2004-06-01 | The purpose of the study is to see how safe and effective and tolerable the use of colesevelam hydrochloride is for type 2 diabetes when added to sulfonylurea alone or in combination with other anti-diabetic drugs. |
NCT00151749 ↗ | WelChol® and Insulin in Treating Patients With Type 2 Diabetes | Completed | Daiichi Sankyo Inc. | Phase 3 | 2004-06-01 | The purpose of the study is to see how safe and effective and tolerable the use of WelChol® is for type 2 diabetes when added to insulin alone or in combination with other anti-diabetic drugs |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for WELCHOL
Condition Name
Clinical Trial Locations for WELCHOL
Trials by Country
Clinical Trial Progress for WELCHOL
Clinical Trial Phase
Clinical Trial Sponsors for WELCHOL
Sponsor Name